Dashboard
Faculty
Programme
Login
Dashboard
Faculty
Programme
Login
Evolving the Clinical Utility of dd-cfDNA (AlloSure/AlloSeq cfDNA) in Organ Transplantation
Wednesday September 14, 2022 from 13:15 to 14:15
Room: A
Using AI to Enhance the Predictive Capability of dd-cfDNA (AlloSure)
Log in to add to favorites
Add Personal Notes
Alexandre Loupy, France
Professor of Nephrology
Paris Transplant Group
Presentations by Alexandre Loupy
Tue-13 from 09:40 - 11:10 in room A
Current advances in organ transplantation
Antibody mediated rejection: from basic to clinic
Tue-13 from 16:25 - 17:25 in room E
Biomarkers & cell free DNA
Development and validation of an integrative dd-cfDNA system to predict allograft rejection: a population based study
Wed-14 from 12:00 - 13:00 in room C5
Xenotransplantation
Histological And Molecular Characterization Of Kidney Xenografts Transplanted To Decedent Humans
Sun-11 from 16:30 - 18:00 in room C3
Allocation and Optimization of Donors at High Risk for Delayed Graft Function
Designing Clinical Trials to Better Define and Manage DGF
Wed-14 from 13:15 - 14:15 in room A
Evolving the Clinical Utility of dd-cfDNA (AlloSure/AlloSeq cfDNA) in Organ Transplantation
Using AI to Enhance the Predictive Capability of dd-cfDNA (AlloSure)
Email:
info@tts2022.org
514-874-1717 x203
© 2024 TTS 2022